share

[6-Cyclopropyl-4-(Methoxycarbonyl)-3-Methyl-1H-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid CAS NO 1011396-63-6


Unit Price:

CAS No.:1011396-63-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

[6-Cyclopropyl-4-(Methoxycarbonyl)-3-Methyl-1H-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is primarily utilized by research organizations, contract development and manufacturing organizations (CDMOs), and pharmaceutical companies engaged in drug discovery and process development.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of investigational new drugs, especially those targeting specific enzyme pathways.
  • Medicinal Chemistry Research: Serves as a versatile scaffold for constructing compound libraries in high-throughput screening and structure-activity relationship (SAR) studies.
  • API Synthesis: Used in the multi-step manufacturing process of complex target molecules for preclinical and clinical development.
  • Biochemical Tool Compound: Potential use in developing probes for studying biological mechanisms and target validation.
  • Custom Synthesis Projects: Employed by CDMOs for client-specific synthesis of novel chemical entities under cGMP or research-grade conditions.

Basic Information

Product Name [6-Cyclopropyl-4-(Methoxycarbonyl)-3-Methyl-1H-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid
CAS No. 1011396-63-6
Molecular Formula C15H15N3O4
Molecular Weight 301.30 g/mol
Synonyms 1H-Pyrazolo[3,4-b]pyridine-1-acetic acid, 6-cyclopropyl-4-(methoxycarbonyl)-3-methyl-; (6-Cyclopropyl-4-methoxycarbonyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid; 1011396-63-6; Pyrazolopyridine acetic acid derivative; Cyclopropyl pyrazolopyridine carboxylate
EINECS Contact for details

Quality Control

Our production of [6-Cyclopropyl-4-(Methoxycarbonyl)-3-Methyl-1H-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid adheres to stringent quality protocols suitable for pharmaceutical R&D and development-scale manufacturing. Each batch is characterized and tested to ensure identity, purity, and consistency. Certificates of Analysis (COA) with detailed chromatographic and spectroscopic data are provided to support your regulatory and research requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and must be kept under anhydrous conditions. For long-term storage, consider using a desiccator or storing under an inert atmosphere.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.